FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 10:26:57 2024-07-16 am EDT | ||
| 6.6 EUR | +22.00% |
|
| Current month | +83.39% | ||
| 1 month | +203.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 6.6 | +22.00% |
| 24-07-15 | 5.41 | -15.34% |
| 24-07-12 | 6.39 | +29.35% |
| 24-07-11 | 4.94 | +27.32% |
| 24-07-10 | 3.88 | +35.19% |
Real-time BOERSE MUENCHEN
Last update July 16, 2024 at 10:26 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GP5393 |
| ISIN | DE000GP53936 |
| Date issued | 2023-05-30 |
| Strike | 308.1 $ |
| Maturity | Unlimited |
| Parity | 3.6 : 1 |
| Emission price | 8.71 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 103.3 € |
|---|---|
| Lowest since issue | 1.2 € |
| Spread | 0.07 € |
| Spread % | 1.12% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
